The brain-tumor related protein podoplanin regulates synaptic plasticity and hippocampus-dependent learning and memory

References

• Nose K, Saito H, Kuroki T. Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Cell Growth Differ. 1990;1:511–18.
   PubMedGoogle Scholar
• Wetterwald A, Hoffstetter W, Cecchini MG, Lanske B, Wagner C, Fleisch H, et al. Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone. 1996;18:125–32.
   PubMed Web of Science ®Google Scholar
• Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol. 1997;151:1141–52.
   PubMed Web of Science ®Google Scholar
• Astarita JL, Acton SE, Turley SJ. Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol. 2012;3:283.
   PubMed Web of Science ®Google Scholar
• Yurrita MM, Fernandez-Munoz B, Del Castillo G, Martin-Villar E, Renart J, Quintanilla M. Podoplanin is a substrate of presenilin-1/γ-secretase. Int J Biochem Cell Biol. 2014;46:68–75.
   PubMed Web of Science ®Google Scholar
• Shimojo M, Sahara N, Mizoroki T, Funamoto S, Morishima-Kawashima M, Kudo T, et al. Enzymatic characteristics of I213T mutant presenilin-1/gamma-secretase in cell models and knock-in mouse brains: familial Alzheimer disease-linked mutation impairs gamma-site cleavage of amyloid precursor protein C-terminal fragment beta. J Biol Chem. 2008;283:16488–96.
   PubMed Web of Science ®Google Scholar
• Uemura K, Farner KC, Hashimoto T, Nasser-Ghodsi N, Wolfe MS, Koo EH, et al. Substrate docking to gamma-secretase allows access of gamma-secretase modulators to an allosteric site. Nature Commun. 2010;1:130.
   PubMed Web of Science ®Google Scholar
• Uemura K, Kuzuya A, Shimozono Y, Aoyagi N, Ando K, Shimohama S, et al. GSK3beta activity modifies the localization and function of presenilin 1. J Biol Chem. 2007;282:15823–32.
   PubMed Web of Science ®Google Scholar
• Xia D, Watanabe H, Wu B, Lee SH, Li Y, Tsvetkov E, et al. Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease. Neuron. 2015;85:967–81.
   PubMed Web of Science ®Google Scholar
• Larrieu-Lahargue F, Welm AL, Bouchecareilh M, Alitalo K, Li DY, Bikfalvi A, et al. Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis. PLoS One. 2012;7:e39540.
   Google Scholar
• Suzuki H, Kato Y, Kaneko MK, Okita Y, Narimatsu H, Kato M. Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma. FEBS Lett. 2008;582:341–5.
   PubMed Web of Science ®Google Scholar
• Uhrin P, Zaujec J, Breuss JM, Olcaydu D, Chrenek P, Stockinger H, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood. 2010;115:3997–4005.
   PubMed Web of Science ®Google Scholar
• Conner JM, Franks KM, Titterness AK, Russell K, Merrill DA, Christie BR, et al. NGF is essential for hippocampal plasticity and learning. J Neurosci. 2009;29:10883–9.
   PubMed Web of Science ®Google Scholar
• Brown MC, Staniszewska I, Lazarovici P, Tuszynski GP, Del Valle L, Marcinkiewicz C. Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. Neuro-Oncology. 2008;10:968–80.
   PubMed Web of Science ®Google Scholar
• Forsyth PA, Krishna N, Lawn S, Valadez JG, Qu X, Fenstermacher DA, et al. p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells. J Biol Chem. 2014;289:8067–85.
   PubMed Web of Science ®Google Scholar
• Hock CH, Heese K, Olivieri G, Hulette CH, Rosenberg C, Nitsch RM, et al. Alterations in neurotrophins and neurotrophin receptors in Alzheimer's disease. J Neural Transm Suppl. 2000;59:171–4.
   PubMedGoogle Scholar
• Lad SP, Neet KE, Mufson EJ. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr Drug Targets CNS Neurol Disord. 2003;2:315–34.
   PubMedGoogle Scholar
• Lapchak PA. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp Neurol. 1993;124:16–20.
   PubMed Web of Science ®Google Scholar
• Rattray M. Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease. Biol Psychiat. 2001;49:185–93.
   PubMed Web of Science ®Google Scholar
• Monje FJ, Kim EJ, Pollak DD, Cabatic M, Li L, Baston A, et al. Focal adhesion kinase regulates neuronal growth, synaptic plasticity and hippocampus-dependent spatial learning and memory. Neuro-Signals. 2012;20:1–14.
   PubMedGoogle Scholar
• Massa F, Koehl M, Wiesner T, Grosjean N, Revest JM, Piazza PV, et al. Conditional reduction of adult neurogenesis impairs bidirectional hippocampal synaptic plasticity. Proc Natl Acad Sci USA. 2011;108:6644–9.
   PubMed Web of Science ®Google Scholar
• Kotani M, Tajima Y, Osanai T, Irie A, Iwatsuki K, Kanai-Azuma M, et al. Complementary DNA cloning and characterization of RANDAM-2, a type I membrane molecule specifically expressed on glutamatergic neuronal cells in the mouse cerebrum. J Neurosci Res. 2003;73:603–13.
   PubMed Web of Science ®Google Scholar
• Pollak D, Weitzdoerfer R, Yang YW, Prast H, Hoeger H, Lubec G. Cerebellar protein expression in three different mouse strains and their relevance for motor performance. Neurochem Int. 2005;46:19–29.
   PubMed Web of Science ®Google Scholar
• Corcoran KA, Donnan MD, Tronson NC, Guzman YF, Gao C, Jovasevic V, et al. NMDA receptors in retrosplenial cortex are necessary for retrieval of recent and remote context fear memory. J Neurosci. 2011;31:11655–9.
   PubMed Web of Science ®Google Scholar
• Pollak DD, John J, Bubna-Littitz H, Schneider A, Hoeger H, Lubec G. Components of the protein quality control system are expressed in a strain-dependent manner in the mouse hippocampus. Neurochem Int. 2006;49:500–7.
   PubMed Web of Science ®Google Scholar
• Pollak DD, John J, Scharl T, Leisch F, Schneider A, Hoeger H, et al. Strain-dependent regulation of neurotransmission and actin-remodelling proteins in the mouse hippocampus. Genes Brain Behav. 2006;5:200–4.
   PubMed Web of Science ®Google Scholar
• Pollak DD, John J, Schneider A, Hoeger H, Lubec G. Strain-dependent expression of signaling proteins in the mouse hippocampus. Neuroscience. 2006;138:149–58.
   PubMed Web of Science ®Google Scholar
• Pollak DD, Scharl T, Leisch F, Herkner K, Villar SR, Hoeger H, et al. Strain-dependent regulation of plasticity-related proteins in the mouse hippocampus. Behav Brain Res. 2005;165:240–6.
   PubMed Web of Science ®Google Scholar
• Schacht V, Ramirez MI, Hong YK, Hirakawa S, Feng D, Harvey N, et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 2003;22:3546–56.
   PubMed Web of Science ®Google Scholar
• Zhao M, Li D, Shimazu K, Zhou YX, Lu B, Deng CX. Fibroblast growth factor receptor-1 is required for long-term potentiation, memory consolidation, and neurogenesis. Biol Psychiat. 2007;62:381–90.
   PubMed Web of Science ®Google Scholar
• Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, Soleiman A, et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol. 2004;15:603–12.
   PubMed Web of Science ®Google Scholar
• Lowe KL, Finney BA, Deppermann C, Hagerling R, Gazit SL, Frampton J, et al. Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development. Blood. 2015;125:3769–77.
   PubMed Web of Science ®Google Scholar
• Kang H, Schuman EM. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science. 1995;267:1658–62.
   PubMed Web of Science ®Google Scholar
• Cox LJ, Hengst U, Gurskaya NG, Lukyanov KA, Jaffrey SR. Intra-axonal translation and retrograde trafficking of CREB promotes neuronal survival. Nature Cell Biol. 2008;10:149–59.
   PubMed Web of Science ®Google Scholar
• Abel T, Kandel E. Positive and negative regulatory mechanisms that mediate long-term memory storage. Brain Res Brain Res Rev. 1998;26:360–78.
   PubMedGoogle Scholar
• Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S, Quintanilla M. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci. 2006;119:4541–53.
   PubMed Web of Science ®Google Scholar
• Fernandez-Munoz B, Yurrita MM, Martin-Villar E, Carrasco-Ramirez P, Megias D, Renart J, et al. The transmembrane domain of podoplanin is required for its association with lipid rafts and the induction of epithelial-mesenchymal transition. Int J Biochem Cell Biol. 2011;43:886–96.
   PubMed Web of Science ®Google Scholar
• Smith SM, Melrose J. Podoplanin is expressed by a sub-population of human foetal rib and knee joint rudiment chondrocytes. Tissue Cell. 2011;43:39–44.
   PubMed Web of Science ®Google Scholar
• Marsick BM, San Miguel-Ruiz JE, Letourneau PC. Activation of ezrin/radixin/moesin mediates attractive growth cone guidance through regulation of growth cone actin and adhesion receptors. J Neurosci. 2012;32:282–96.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Agosti C, Solomon F. Response of radixin to perturbations of growth cone morphology and motility in chick sympathetic neurons in vitro. Cell Motil Cytoskeleton. 1996;34:122–36.
   PubMed Web of Science ®Google Scholar
• Olsson PA, Korhonen L, Mercer EA, Lindholm D. MIR is a novel ERM-like protein that interacts with myosin regulatory light chain and inhibits neurite outgrowth. J Biol Chem 1999;274:36288–92.
   PubMed Web of Science ®Google Scholar
• Vinores SA, Perez-Polo JR. Nerve growth factor and neural oncology. J Neurosci Res. 1983;9:81–100.
   PubMed Web of Science ®Google Scholar
• Marushige Y, Marushige K, Koestner A. Chemical control of growth and morphological characteristics of anaplastic glioma cells. Anticancer Res. 1989;9:1729–35.
   PubMed Web of Science ®Google Scholar
• Li QY, Yang Y, Zhang Y, Zhang ZJ, Gong AH, Yuan ZC, et al. Nerve growth factor expression in astrocytoma and cerebrospinal fluid: a new biomarker for prognosis of astrocytoma. Chin Med J (Engl). 2011;124:2222–7.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang Y, Gong A, Wang C, Liang Y, Chen Y. Localization of NGF and TrkA at mitotic apparatus in human glioma cell line U251. Biochem Biophys Res Commun. 2005;337:68–74.
   PubMed Web of Science ®Google Scholar
• Singer HS, Hansen B, Martinie D, Karp CL. Mitogenesis in glioblastoma multiforme cell lines: a role for NGF and its TrkA receptors. J Neurooncol. 1999;45:1–8.
   PubMed Web of Science ®Google Scholar
• Tuszynski MH, Yang JH, Barba D, U HS, Bakay RA, Pay MM, et al. Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease. JAMA Neurol. 2015;72:1139–47.
   PubMed Web of Science ®Google Scholar
• Terry Jr AV, Kutiyanawalla A, Pillai A. Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in rats. Physiol Behav. 2011;102:149–57.
   PubMed Web of Science ®Google Scholar
• Calissano P, Matrone C, Amadoro G. Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease. Develop Neurobiol. 2010;70:372–83.
   PubMed Web of Science ®Google Scholar
• Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav. 2008;7:43–56.
   PubMed Web of Science ®Google Scholar
• Xu W, Weissmiller AM, White 2nd JA, Fang F, Wang X, Wu Y, et al. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration. J Clin Invest. 2016;126:1815–33.
   PubMed Web of Science ®Google Scholar
• Xu CJ, Wang JL, Jin WL. The emerging therapeutic role of NGF in Alzheimer's disease. Neurochem Res. 2016;41:1211–18.
   PubMed Web of Science ®Google Scholar
• Tuszynski MH, Thal L, U HS, Pay MM, Blesch A, Conner J, et al. Nerve growth factor gene therapy for Alzheimer's disease. J Mol Neurosci. 2002;19:207.
   PubMed Web of Science ®Google Scholar